Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gal

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
American Journal of Hospital Pharmacy|December 1, 1983
Variables affecting creatinine clearance predictionW T Sawyer, B R Canaday, T E Poe, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 19, 2016
Effective contact and outcome after pulmonary vein isolation in novel circular multi-electrode atrial fibrillation ablationP Gal, T J Buist, J J J Smit, et al.
Pharmacotherapy|February 24, 2001
A multicenter evaluation of gentamicin therapy in the neonatal intensive care unitM L Glover, C L Shaffer, C M Rubino, et al.
Biochemistry|May 5, 1992
Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complexC Luo, N M Thielens, J Gagnon, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification process. I. Role delineation study. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyG E Dukes, P Gal, W A Miller, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification examination. II. Blueprint to examination. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyR L Talbert, P Gal, G E Dukes, et al.
Pharmacotherapy|May 1, 1993
Pharmacotherapy specialty certification examination. IV. 1992 results and process modifications, including recertification. The 1992 Specialty Council on Pharmacotherapy, Board of Pharmaceutical SpecialtiesB J Zarowitz, P H Vlasses, G E Dukes, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification examination. III. Results of initial administration. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyP H Vlasses, D R Rush, G E Dukes, et al.
Frontiers in Immunology|October 3, 2022
Cardiovascular risk factors: The effects of ageing and smoking on the immune system, an observational clinical studyH W Grievink, V Smit, B W Huisman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 22, 2019
Body mass index related electrocardiographic findings in healthy young individuals with a normal body mass indexG J Hassing, H E C van der Wall, G J P van Westen, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
American Journal of Hospital Pharmacy|December 1, 1983
Variables affecting creatinine clearance predictionW T Sawyer, B R Canaday, T E Poe, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 19, 2016
Effective contact and outcome after pulmonary vein isolation in novel circular multi-electrode atrial fibrillation ablationP Gal, T J Buist, J J J Smit, et al.
Pharmacotherapy|February 24, 2001
A multicenter evaluation of gentamicin therapy in the neonatal intensive care unitM L Glover, C L Shaffer, C M Rubino, et al.
Biochemistry|May 5, 1992
Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complexC Luo, N M Thielens, J Gagnon, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification process. I. Role delineation study. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyG E Dukes, P Gal, W A Miller, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification examination. II. Blueprint to examination. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyR L Talbert, P Gal, G E Dukes, et al.
Pharmacotherapy|May 1, 1993
Pharmacotherapy specialty certification examination. IV. 1992 results and process modifications, including recertification. The 1992 Specialty Council on Pharmacotherapy, Board of Pharmaceutical SpecialtiesB J Zarowitz, P H Vlasses, G E Dukes, et al.
Pharmacotherapy|January 1, 1992
Pharmacotherapy specialty certification examination. III. Results of initial administration. The Board of Pharmaceutical Specialties' Specialty Council on PharmacotherapyP H Vlasses, D R Rush, G E Dukes, et al.
Frontiers in Immunology|October 3, 2022
Cardiovascular risk factors: The effects of ageing and smoking on the immune system, an observational clinical studyH W Grievink, V Smit, B W Huisman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 22, 2019
Body mass index related electrocardiographic findings in healthy young individuals with a normal body mass indexG J Hassing, H E C van der Wall, G J P van Westen, et al.
Pageof 12